PREVIOUS
✖
Sanofi and GSK - receives approval
July 12 , 2021
1209 days
695
0
- Sanofi and GlaxoSmithKline (GSK) have received the approval for the Phase 3 clinical trials in India for their COVID-19 vaccine candidate.
- Sanofi is a French pharmaceutical company.
- GlaxoSmithKline is a British pharmaceutical company.
Leave a Reply
Your Comment is awaiting moderation.